Wei-Hu Wang
Overview
Explore the profile of Wei-Hu Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
1164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Y, Song M, Li S, Tie J, Zhu X, Li Y, et al.
Transl Oncol
. 2025 Feb;
53:102313.
PMID: 39908966
Purpose: Although classified as one stage, T4b rectal cancer actually represents a group of heterogeneous diseases. Our study aimed to assess the prognosis difference of T4b rectal cancer involving inferior...
2.
Wei Y, Liu W, Qi F, Zhang C, Zheng B, Xie Y, et al.
Ann Hematol
. 2023 Oct;
103(1):163-174.
PMID: 37817010
The present study aimed to investigate the clinical features, prognosis, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma (ENKTCL). This real-world study retrospectively reviewed 56 newly diagnosed advanced-stage...
3.
Wei Y, Qi F, Zheng B, Zhang C, Xie Y, Chen B, et al.
Int J Cancer
. 2023 Aug;
153(9):1643-1657.
PMID: 37539660
The study investigated the treatment and prognosis of advanced-stage extranodal natural killer/T-cell lymphoma (ENKTL). With a median follow-up of 75.03 months, the median overall survival (mOS) for the 195 newly...
4.
Chen P, Wang L, Sun T, Yao Y, Peng Y, Zhao J, et al.
Gastroenterol Rep (Oxf)
. 2023 Apr;
11:goad017.
PMID: 37082450
Background: Induction chemotherapy combined with neoadjuvant chemoradiotherapy has been recommended for patients with high-risk, locally advanced rectal cancer. However, the benefit of more intensive total neoadjuvant treatment (TNT) is unknown....
5.
Sheng X, Wang H, Li S, Zhang Y, Geng J, Zhu X, et al.
World J Gastrointest Oncol
. 2022 Oct;
14(9):1711-1726.
PMID: 36187388
Background: The effects of consolidation chemotherapy (CC) in neoadjuvant therapy in locally advanced rectal cancer (LARC) have been explored. However, the optimal neoadjuvant chemoradiotherapy (NCRT) and surgery interval, regimen, and...
6.
Wang L, Zhang X, Zhao Y, Li S, Li Z, Sun Y, et al.
Ann Surg
. 2022 Jun;
277(4):647-654.
PMID: 35766394
Objective: To assess the efficacy and safety of intentional watch and wait (W&W) and organ preservation surgery following neoadjuvant chemoradiotherapy plus consolidation CAPEOX in magnetic resonance imaging (MRI)-defined low-risk rectal...
7.
Zhang Y, Zhu X, Song M, Yao K, Li S, Geng J, et al.
World J Gastrointest Oncol
. 2022 Jun;
14(5):1027-1036.
PMID: 35646284
Background: Accurate target volume delineation is the premise for the implementation of precise radiotherapy. Inadequate target volume delineation may diminish tumor control or increase toxicity. Although several clinical target volume...
8.
Zhang X, Liu X, Li X, Wang L, Zhu H, Sun R, et al.
Int J Colorectal Dis
. 2022 May;
37(6):1239-1249.
PMID: 35503128
Purpose: Current low anterior resection syndrome (LARS) score is lagging behind and only based on clinical symptoms patient described. Preoperative imaging indicators which can be used to predict LARS is...
9.
Li N, Zhu Y, Liu L, Feng Y, Wang W, Wang J, et al.
JAMA Netw Open
. 2021 Nov;
4(11):e2136116.
PMID: 34846525
Importance: Several studies have explored the efficacy and toxic effects of concurrent 5-fluorouracil (5-FU)- or capecitabine-based chemoradiotherapy (CRT) with or without oxaliplatin in the neoadjuvant setting. Addition of oxaliplatin to...
10.
Wang X, Wang W, Wang S, Song Y, Liu Y, Tang Y, et al.
World J Gastrointest Oncol
. 2021 Nov;
13(10):1532-1543.
PMID: 34721783
Background: Adjuvant chemoradiotherapy (ACRT) with oral capecitabine and intensity-modulated radiotherapy (IMRT) were well tolerated in a phase I study in patients who had undergone partial or total gastrectomy for locally...